Details for New Drug Application (NDA): 215016
✉ Email this page to a colleague
The generic ingredient in SIROLIMUS is sirolimus. There are twenty-one drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sirolimus profile page.
Summary for 215016
Tradename: | SIROLIMUS |
Applicant: | Torrent |
Ingredient: | sirolimus |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 215016
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 1MG/ML | ||||
Approval Date: | Dec 27, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription